MS
ABBV icon

Maven Securities’s AbbVie ABBV Stock Holding History

Maven Securities’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.7M Buy
63,000
+13,200
+27% +$2.93M 0.26% 83
2025
Q4 		$11.4M Buy
49,800
+16,700
+50% +$3.8M 0.25% 95
2025
Q3 		$7.66M Buy
33,100
+7,400
+29% +$1.51M 0.19% 112
2025
Q2 		$4.77M Buy
25,700
+4,100
+19% +$762K 0.11% 179
2025
Q1 		$4.53M Sell
21,600
-35,600
-62% -$6.92M 0.14% 137
2024
Q4 		$10.2M Buy
57,200
+20,900
+58% +$3.84M 0.25% 76
2024
Q3 		$7.17M Buy
36,300
+14,100
+64% +$2.63M 0.14% 123
2024
Q2 		$3.81M Buy
+22,200
New +$3.68M 0.08% 250
2024
Q1 		– Sell
-5,200
Closed -$806K – 341
2023
Q4 		$806K Sell
5,200
-11,300
-68% -$1.65M 0.02% 531
2023
Q3 		$2.46M Buy
16,500
+11,500
+230% +$1.69M 0.03% 343
2023
Q2 		$674K Sell
5,000
-34,400
-87% -$5.04M 0.01% 542
2023
Q1 		$6.28M Buy
39,400
+23,300
+145% +$3.56M 0.13% 109
2022
Q4 		$2.6M Sell
16,100
-1,300
-7% -$199K 0.06% 193
2022
Q3 		$2.33M Buy
17,400
+7,700
+79% +$1.1M 0.04% 279
2022
Q2 		$1.49M Sell
9,700
-25,300
-72% -$3.87M 0.05% 276
2022
Q1 		$5.67M Sell
35,000
-16,100
-32% -$2.34M 0.2% 74
2021
Q4 		$6.92M Buy
51,100
+17,900
+54% +$2.11M 0.2% 64
2021
Q3 		$3.58M Buy
33,200
+6,000
+22% +$686K 0.12% 126
2021
Q2 		$3.06M Buy
27,200
+13,800
+103% +$1.55M 0.12% 147
2021
Q1 		$1.45M Sell
13,400
-6,400
-32% -$685K 0.06% 288
2020
Q4 		$2.12M Buy
19,800
+15,800
+395% +$1.52M 0.21% 118
2020
Q3 		$351K Buy
+4,000
New +$377K 0.03% 449

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Maven Securities's ABBV Position: Q1 2026 in Review

Maven Securities sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 13,530 shares — an estimated $3M sold.

Maven Securities first reported a position in ABBV in Q4 2020 and held it in 12 quarters. The position peaked at $3.1M in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Maven Securities reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Maven Securities sold 13,530 AbbVie shares in Q1 2026, an estimated $3M.
  • Maven Securities first reported a position in AbbVie in Q4 2020 and held it in 12 quarters.
  • Maven Securities's AbbVie position peaked at $3.1M in Q4 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Maven Securities's 13F filing for Q1 2026, filed 15 May 2026.